On February 16, 2021 Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering novel epigenetic therapies, reported that management will host a conference call and webcast to discuss its fourth quarter and full year 2020 financial results and other business highlights and will participate in two upcoming investor conferences (Press release, Epizyme, FEB 16, 2021, View Source [SID1234575134]). Details of the events are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Fourth Quarter and Full Year 2020 Financial Results: Management will host a conference call and webcast to discuss its fourth quarter and full year 2020 financial results on Tuesday, February 23, 2021 at 8:00 a.m. ET. To participate in the conference call, please dial (877) 844-6886 (domestic) or (970) 315-0315 (international) and refer to conference ID 3719819.
Cowen and Company’s 41st Annual Healthcare Conference: Robert Bazemore, President and Chief Executive Officer, will participate in a panel discussion on Thursday, March 4, 2021 at 12:10 p.m. ET.
Barclays Global Healthcare Conference: Management will participate in the Barclays Global Healthcare Conference on Tuesday, March 9, 2021, with a company overview to be presented at 8:00 a.m. ET.
Live webcasts will be available in the investor section of the company’s website at www.epizyme.com, and will be archived for 60 days following the call.